Investor Area

Home / Investor Area / News / CLINUVEL Chair to Retire Following FDA Approval
 

CLINUVEL Chair to Retire Following FDA Approval

 

CLINUVEL PHARMACEUTICALS LTD today announced that Mr Stan McLiesh will retire from his role as Non-Executive Director and Chair of the Board on 30 November 2019. Non-Executive Director Mr Willem Blijdorp has been elected Chair and will take on the role on 30 November 2019. […]

Download PDF